Richard DiMarchi has been appointed CEO and Thomas Daniel has become chief scientific officer of San Diego-based Ambrx. DiMarchi, one of the founders of Ambrx, was previously group vice president for biotechnology and product development at Lilly Research Laboratories, where he co-invented Humalog, the first biosynthetic protein approved for human use. He is a professor of chemistry at Indiana University and a member of Inproteo.
Daniel was previously vice president of research at Amgen, and was senior vice president of dis-covery research at Immunex before Amgen acquired it. He was also previously a professor of medicine and cell biology at Vanderbilt University and director of the Vanderbilt Center for Vascular Biology.
Camron Nezhat has been appointed to the scientific advisory board of CombiMatrix. Nezhat is a surgeon at Stanford University. He was the inventor of video laparoscopy, a now popular minimally invasive surgical technique for abdominal and pelvic surgery.